Thus, the development of ductal carcinoma in situ (DCIS) would be more heavily dependent on external factors modulated by ER and HER2, while the progression to invasive cancer would be less dependent on this route, possibly because of the progressive accumulation of genetic alterations that occur in the malignant cells.26-29. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.